CTOs on the Move

Erie Family Health Center

www.eriefamilyhealth.org

 
At Erie Family Health Centers, we believe health care is a right, not a privilege. Our mission is to provide accessible, affordable and high quality health care for those in need. Since 1957, when the Erie was first established as a volunteer clinic by doctors from Northwestern Memorial Hospital, it has been Erie`s mission to ensure that all Chicagoans have access to high quality, culturally sensitive, bilingual health care services — regardless of their ability to pay. Today, Erie serves over 74,000 patients annually at thirteen sites, including seven large primary health centers, five school-based health centers, a teen health center, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

eTherapi

eTherapi is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SPEAR Physical Therapy

The American Physical Therapy Associations top-ranked private physical therapy practice, and the top-rated physical therapists in New York City.

GlobalMed Group

GlobalMed Group is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Convaquip Industries Inc

Convaquip Industries Inc is a Abilene, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.